Molecular Imaging Market Size Trends And Growth Analysis
Molecular imaging refers to the visualization, characterization, and measurement of biological processes at the molecular and cellular levels in humans and other living systems. It allows researchers to observe and measure processes in living systems, without disturbing them. Molecular imaging plays a vital role in disease diagnosis, drug development, and personalized medicine by allowing researchers to visualize and monitor biological processes at the molecular level.
It helps identify abnormalities at the earliest stage and enables targeted drug delivery. The Molecular Imaging Market Demand utilizes imaging modalities such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), ultrasound, and optical imaging to capture spatial and temporal information about molecular and biochemical processes associated with normal and abnormal biological functions.
The Global molecular imaging market is estimated to be valued at US$ 6.8 billion in 2024 and is expected to exhibit a CAGR of 5.6% over the forecast period 2024-2029.
Key Takeaways
Key players: Key players operating in the molecular imaging market are General Electric Company, Koninklijke Philips N.V., Siemens Healthineers, Bruker, Mediso Ltd., MILabs B.V., FUJIFILM VisualSonics Inc., and PerkinElmer, Inc.
Key opportunities: Growing investments by public and private organizations in molecular imaging is anticipated to offer immense opportunities for market growth. In addition, increasing applications of molecular imaging in drug development and personalized medicine also provide opportunities for market expansion.
Get More Insights On, Molecular Imaging Market
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian